Loading…
Loading…
PURE does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for PURE and 80,000+ other tickers.
See exactly how PURE's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for PURE and 80,000+ other tickers.
PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company’s technology platform contains silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a ready-to-use hard surface disinfectant and food contact surface sanitizer and disinfectant; PURE Control…
The 35-state operator consolidates onto AppFolio as it scales toward a 60,000-unit portfolio The 35-state operator consolidates onto AppFolio as it scales toward a 60,000-unit portfolio
VANCOUVER, British Columbia, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Purecore Metals Inc. (CSE: PURE) (FSE: J8Y) (OTCQB: PPURF) (“Purecore” or the “Company”) is pleased to provide a corporate update highlighting progress since its common shares commenced trading on the Canadian Securities Exchange on May 15, 2026.
VANCOUVER, British Columbia, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Purecore Metals Inc. (CSE: PURE) (FSE: J8Y) (OTCQB: PPURF) ("Purecore" or the "Company") announces that its common shares have commenced trading on the OTCQB Venture Market in the United States under the symbol "PPURF". Highlights Purecore common shares now trade on the OTCQB Venture Market in the United States under the symbol "PPURF".
First completed fund tokenization on the Caliber platform, part of an initial program of approximately $100 million of Managed Assets slated for tokenization First completed fund tokenization on the Caliber platform, part of an initial program of approximately $100 million of Managed Assets slated for tokenization
Shares of PURE Bioscience (OTCMKTS:PURE - Get Free Report) crossed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $0.07 and traded as high as $0.07. PURE Bioscience shares last traded at $0.07, with a volume of 275 shares traded. PURE Bioscience Trading Up 7.7% The